India Glycols Limited
Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals.
What India files
- Others80
- Important56
- Investor Meet28
- PPTs12
- Updates11
- Dividend/Bonus9
India Glycols has fixed the key dates for its demerger scheme post NCLT sanction. Shareholders will receive 1 Ennature Bio Pharma share for every 3 held, and 1 IGL Spirits share for every 1 held. New shares will be listed.
India Glycols is holding an earnings conference call for Q1 FY27 results. Key management, including the CEO and CFO, will discuss performance and outlook. Investors can join the call for insights.
NCLT reserved its order on India Glycols' demerger scheme with IGL Spirits. This key business development awaits final NCLT approval after hearing arguments, including a minor Rs. 27,890 tax dispute. The company committed to addressing any outstanding dues post-sanction.
India Glycols has announced an earnings conference call on May 18 at 4 PM IST. Management will discuss financial results for Q4 and Full Year FY26, offering insights into performance.
India Glycols will host an earnings conference call to discuss financial results for Q3 & 9M FY26. Management will provide insights into the company's performance and outlook.